Reperfusão mecânica no infarto agudo do miocárdio

Devito, Fernando; Sousa, Amanda G. M. R; Berti, Sergio; Mattos, Luiz Alberto P; Feres, Fausto; Abizaid, Alexandre; Staico, Rodolfo; Chaves, Aurea; Abizaid, Andrea C. L. S; Sousa, José Eduardo M. R.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 11(4): 853-865, jul.-ago. 2001. tab, graf
Artículo en Portugués | LILACS, SES-SP | ID: lil-394933

Documentos relacionados

  1. Long term antithrombotic threapy after myocardial infarction: why, to whom and which one?
  2. Antithrombotic Activity of the Antiplatelet Agent Angipur on the Model of Arterial Thrombosis in Rats with Isoproterenol-Induced Myocardial Infarction.
  3. Acute myocardial infarction during pregnancy.
  4. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.
  5. Antithrombotic therapies in primary angioplasty: rationale, results and future directions.
  6. Intracoronary antithrombotic therapy during primary percutaneous coronary intervention in patients with STEMI: A systematic review and network meta-analysis.
  7. Effects of a New Antithrombotic Drug GRS, a Soluble Guanylate Cyclase Stimulator, on Endothelial Dysfunction in Rats with Myocardial Infarction.
  8. Protecting patients during a shortage of thrombolytic agents.
  9. Optimal Antithrombotic Therapy Beyond 1-Year After Coronary Revascularization in Patients With Atrial Fibrillation.
  10. Fibrinolysis: a Misunderstood Natural Defense Whose Therapeutic Potential Is Unknown.